135 related articles for article (PubMed ID: 10890192)
41. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
[TBL] [Abstract][Full Text] [Related]
42. Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression.
Jin L; Chandler WF; Smart JB; England BG; Lloyd RV
J Clin Endocrinol Metab; 1993 Mar; 76(3):728-35. PubMed ID: 7680355
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues.
Hosoi E; Yokogoshi Y; Hosoi E; Horie H; Sano T; Yamada S; Saito S
Acta Endocrinol (Copenh); 1993 Oct; 129(4):301-6. PubMed ID: 8237246
[TBL] [Abstract][Full Text] [Related]
44. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
[TBL] [Abstract][Full Text] [Related]
45. High level expression of Prop-1 gene in gonadotropic cell lines.
Aikawa S; Sato T; Ono T; Kato T; Kato Y
J Reprod Dev; 2006 Apr; 52(2):195-201. PubMed ID: 16394624
[TBL] [Abstract][Full Text] [Related]
46. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
47. Expression of mPOU protein in the human pituitary adenomas.
Sakagami Y; Okimura Y; Kondoh T; Iguchi G; Fumoto M; Kuno T; Chihara K; Kohmura E
Kobe J Med Sci; 2003; 49(5-6):117-22. PubMed ID: 15141147
[TBL] [Abstract][Full Text] [Related]
48. Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.
Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Figarella-Branger D; Cortet-Rudelli C; Grisoli F; Jaquet P; Enjalbert A
J Clin Endocrinol Metab; 1996 Sep; 81(9):3390-6. PubMed ID: 8784102
[TBL] [Abstract][Full Text] [Related]
49. Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas.
Giorgi RR; Correa-Giannella ML; Casarini AP; Machado MC; Bronstein MD; Cescato VA; Giannella-Neto D
Neuroendocrinology; 2005; 82(3-4):208-14. PubMed ID: 16601360
[TBL] [Abstract][Full Text] [Related]
50. Transcript abundance in mouse pituitaries with altered growth hormone expression quantified by reverse transcriptase polymerase chain reaction implicates transcription factor Zn-16 in gene regulation in vivo.
Wojtkiewicz PW; Phelps CJ; Hurley DL
Endocrine; 2002 Jun; 18(1):67-74. PubMed ID: 12166626
[TBL] [Abstract][Full Text] [Related]
51. Basic science and clinical research advances in the pituitary transcription factors: Pit-1 and Prop-1.
Kerr J; Wood W; Ridgway EC
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):359-63. PubMed ID: 18594277
[TBL] [Abstract][Full Text] [Related]
52. Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas.
Ikuyama S; Mu YM; Ohe K; Nakagaki H; Fukushima T; Takayanagi R; Nawata H
Clin Endocrinol (Oxf); 1998 May; 48(5):647-54. PubMed ID: 9666878
[TBL] [Abstract][Full Text] [Related]
53. Clinical and molecular features of a TSH-secreting pituitary microadenoma.
Usui T; Izawa S; Sano T; Tagami T; Nagata D; Shimatsu A; Takahashi JA; Naruse M
Pituitary; 2005; 8(2):127-34. PubMed ID: 16379036
[TBL] [Abstract][Full Text] [Related]
54. Pathophysiology of pituitary adenomas.
Donangelo I; Melmed S
J Endocrinol Invest; 2005; 28(11 Suppl International):100-5. PubMed ID: 16625857
[TBL] [Abstract][Full Text] [Related]
55. Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas.
Oka H; Jin L; Reubi JC; Qian X; Scheithauer BW; Fujii K; Kameya T; Lloyd RV
Am J Pathol; 1998 Dec; 153(6):1787-96. PubMed ID: 9846969
[TBL] [Abstract][Full Text] [Related]
56. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
[TBL] [Abstract][Full Text] [Related]
57. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
58. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.
Yamada S; Sano T; Stefaneanu L; Kovacs K; Aiba T; Sawano S; Shishiba Y
J Clin Endocrinol Metab; 1993 Feb; 76(2):352-6. PubMed ID: 8432778
[TBL] [Abstract][Full Text] [Related]
59. Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas.
Normann KR; Øystese KAB; Berg JP; Lekva T; Berg-Johnsen J; Bollerslev J; Olarescu NC
Mol Cell Endocrinol; 2016 Dec; 437():183-189. PubMed ID: 27561203
[TBL] [Abstract][Full Text] [Related]
60. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]